Arcadia Biosciences Inc.
RKDA | NASDAQ
$0.47
$0.00 (-0.32%)
Nov 2, 2026, 10:33 AM ET · Market open
Market Data
Market Cap $729.56K
Enterprise Value $-3.45M
Beta 0.55
Average Volume 3.09M
Shares Outstanding (Diluted) 1.37M
Shares Change YoY 0.07%
Institutional Ownership 25.54%
Exchange NASDAQ
ISIN US0390143032
Price Performance
Price Change 1M -27.5%
Price Change 3M -54.2%
Price Change 6M -76.1%
Price Change YTD -78.1%
Price Change 1Y -86.1%
Price Change 3Y -88.4%
Price Change 5Y -99.5%
1M CAGR (ann.) -25.3%
1Y CAGR (ann.) -87.0%
5Y CAGR (ann.) -64.5%
All-Time CAGR -56.3%
Valuation
PE Ratio -0.06
Forward PE N/A
PEG Ratio 0.00
Forward PEG N/A
PS Ratio 0.15
Forward PS N/A
PB Ratio 1.15
P/FCF Ratio -0.29
P/Adj. FCF Ratio -0.28
P/OCF Ratio -0.25
EV/Sales -0.73
EV/EBIT 0.31
EV/EBITDA 0.31
EV/FCF 1.36
Earnings Yield -1734.0%
FCF Yield -347.6%
Adj. FCF Yield -361.2%
Financial Health
Net Cash $4.18M
Total Debt $0
Cash & Short-Term Investments $4.18M
Total Assets $5.89M
Current Ratio 3.49
Quick Ratio 2.92
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score -73.84
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 34.6%
Operating Profit Margin -85.5%
EBITDA Margin -234.1%
Net Profit Margin -234.5%
FCF Margin -53.4%
Adj. FCF Margin -55.5%
SBC / Revenue 2.1%
SBC Impact (per share) -3.9%
Returns
Return on Assets -188.9%
Return on Equity -339.9%
Return on Invested Capital -95.6%
Return on Capital Employed -95.6%
Return on Tangible Assets -190.1%
Historical Growth (CAGR)
Revenue CAGR 3Y -13.2%
Revenue CAGR 5Y -9.6%
Revenue CAGR 10Y -1.1%
EPS CAGR 3Y 31.1%
EPS CAGR 5Y 18.6%
EPS CAGR 10Y 10.0%
FCF CAGR 3Y 22.1%
FCF CAGR 5Y 17.1%
FCF CAGR 10Y 6.9%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 5
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 5, 2026
EPS Estimate (next Q) -$0.46
EPS Growth Est (next Q) -174.2%
Revenue Est (next Q) $2.4M
Revenue Growth Est (next Q) 84.3%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $6.00
Price Target Upside 1176.6%
Cash Flow
Operating Cash Flow $-2.54M
Free Cash Flow $-2.54M
Adj. Free Cash Flow $-2.64M
FCF Per Share -$1.85
OCF Per Share -$1.85
OCF/S Ratio -53.4%
Income Statement
Revenue $4.75M
Gross Profit $1.64M
Operating Income $-4.06M
EBITDA $-11.11M
Net Income $-11.13M
EPS (Diluted) -$8.15
Revenue / Employee $593.25K
Profit / Employee $-1.39M
Employees 8
Add to Watchlist
Select watchlists to add or remove RKDA